/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

AT&T is the First to Offer Mobile 5G in 7 More U.S. Cities

Published

5 years ago

April 10, 2019

Reading Time: 3 minutes

AT&T¹ mobile 5G service is now live in parts of 7 more cities, including Austin, Los Angeles, Nashville, Orlando, San Diego, San Francisco, and San Jose. There are now 19 cities across the nation where AT&T is the only carrier to offer mobile 5G service to businesses and consumers, well ahead of our competition.

“Last December we officially introduced the nation’s first commercial mobile 5G service,” said Andre Fuetsch, president AT&T Labs and chief technology officer. “We spent the early part of this year accelerating and advancing our 5G network with early adopters by our side. And now it’s time to offer this experience to more businesses and consumers in another 7 cities.”

After being the first company to offer both a live mobile 5G network and a commercially available 5G device in the U.S. last December, we continued to push for faster speeds. As a result, last month we were the first in the nation to surpass 1 gigabit mobile speeds on a live 5G connection. We are also working with some of the most innovative companies in the world to imagine and create new experiences only possible on 5G.

As we continue to expand our ultra-fast 5G network, we expect that by early 2020 we’ll have the best combination of mobile 5G – providing both the higher speeds available over mmWave spectrum and nationwide coverage available over “sub-6” spectrum.

These network accomplishments are in addition to AT&T offering the best², as well as the fastest³ wireless network in the nation for existing customers with the latest smartphones. It’s clear in these results, our customers are already seeing the benefits of our investment in our 5G Evolution technologies, our first step in our transition from LTE to mobile 5G.

Insights from 5G Customers

We called our shot in January 2018 stating we were going to be the first U.S. company to launch mobile 5G service by the end of the year. This promise jumpstarted the device and network ecosystem. It became a reality when we made the NETGEAR Nighthawk 5G mobile hotspot available to businesses and consumers in December.

Our early business customers that have been on our 5G network since late 2018 are already seeing the promise of this network come to life.

“We transfer a lot of data. Like, a lot. The 5G hotspot is a great way for us to transfer these files, particularly on site, without bogging down our process,” said Mike Ballerino, Director of Construction at HCS Inc. General Contractor. “With our 2 5G mobile hotspots, we can keep workflows moving smoothly, perfect for when we’re out at a construction site and not in the office. That helps us get our jobs done faster than we could before.”

“Architecture is more than just designing buildings for people to live and work in. It’s about finding the right ways to inspire the people in those buildings,” said Erik Schlegel, Director of Technology at RATIO Architects. “Emerging technology continues to play a huge role in our LiveDesign^SM process, and we’re at an exciting point in exploring how we can use the 5G hotspot to take collaboration a step further with faster network connectivity.”

Mobile 5G Device Availability

In 2019 we plan to offer at least three 5G mobile devices. We’re on track to make our next mobile 5G device, the Samsung Galaxy S10 5G smartphone, available this spring. It will give customers the ability to not just ‘have the power of 5G in their hands’, but actually be able to take advantage of the next generation of connectivity.

Later this year we’ll bring another Samsung 5G smartphone to stores, giving customers the ability to take advantage of our 5G leadership in both speed and coverage. This smartphone will be able to access both mmWave and sub-6 spectrum.

SOURCE AT&T Communications

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

21 hours ago

April 18, 2024

GlobeNewswire

transfer

IMC to transfer its Oranim Pharmacy shares back to the seller

Published

3 days ago

April 16, 2024

CISION (PR Newswire)

imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller

TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the seller.

“With the April 1^st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, the occurrence of growth opportunities and the likelihood of growth potential.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html